Disc Medicine Cash Flow Statement Analysis

Operating, investing, and financing activities in millions USD

Scroll to see more
Cash flow statement showing operating, investing, and financing activities for Disc Medicine, Inc. (IRON) - Annual data in millions USD
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Operating Activities
Net Income-109.36-76.43-46.83-35.97-40.84
Depreciation & Amortization0.160.100.090.030.32
Stock Based Compensation16.825.532.090.510.12
Change in Working Capital3.23-2.902.131.29-0.73
Change in Accounts Payable-4.68-3.740.531.32-0.51
Change in Other Working Capital7.910.791.601.561.01
Other Operating Activities-4.775.770.271.566.86
Net Cash from Operating Activities-93.93-73.46-42.25-27.53-32.71
Investing Activities
Capital Expenditures-0.510.09-0.15-0.070.02
Purchases of Investments-386.630.000.000.000.00
Sales/Maturities of Investments94.800.000.000.00-120.75
Other Investing Activities0.000.000.000.00-120.75
Net Cash from Investing Activities-292.33-0.09-0.15-0.07-0.02
Financing Activities
Debt Repayment28.990.000.00-4.58-0.20
Common Stock Issued187.30199.08151.120.0720.08
Other Financing Activities2.0237.58-2.14195.880.00
Net Cash from Financing Activities218.31239.38148.9889.9334.25
Summary
Net Change in Cash-167.94165.83106.5862.331.52
Cash at Beginning of Period360.62194.7988.2125.893.31
Cash at End of Period192.67165.83194.7988.213.76
Free Cash Flow-94.43-73.55-42.40-27.60-32.73
Supplemental Disclosures
Interest Paid0.200.000.000.310.35
Income Taxes Paid0.300.110.000.000.00